Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1441

1.
2.

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH.

Hepatology. 2004 Jan;39(1):42-50.

PMID:
14752821
3.

[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].

Cao XX, Li J, Qiu LM, Luo YW, Chen YH, Ran Y.

Zhonghua Gan Zang Bing Za Zhi. 2009 Sep;17(9):641-4. Chinese.

PMID:
19785947
4.
5.

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.

Sun J, Wang Z, Ma S, Zeng G, Zhou Z, Luo K, Hou J.

J Med Virol. 2005 Mar;75(3):391-8.

PMID:
15648063
6.

Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.

Chen RY, Bowden S, Desmond PV, Dean J, Locarnini SA.

J Gastroenterol Hepatol. 2003 Jun;18(6):630-7.

PMID:
12753143
7.

Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.

Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y.

J Gastroenterol Hepatol. 2005 Mar;20(3):441-9.

PMID:
15740490
8.

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.

Kuwahara R, Kumashiro R, Murashima S, Ogata K, Tanaka K, Hisamochi A, Hino T, Ide T, Tanaka E, Koga Y, Sata M.

J Med Virol. 2004 Jan;72(1):26-34.

PMID:
14635007
9.

Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.

Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.

J Med Virol. 2007 Nov;79(11):1664-70.

PMID:
17854034
10.

Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.

Chen CH, Lee CM, Lu SN, Changchien CS, Wang JC, Wang JH, Hung CH, Hu TH.

J Hepatol. 2006 Jan;44(1):76-82. Epub 2005 Sep 23.

PMID:
16298013
11.

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.

Chang TT, Lai CL, Chien RN, Guan R, Lim SG, Lee CM, Ng KY, Nicholls GJ, Dent JC, Leung NW.

J Gastroenterol Hepatol. 2004 Nov;19(11):1276-82.

PMID:
15482535
12.

Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.

Kazim SN, Chauhan R, Das BC, Sarin SK.

J Gastroenterol Hepatol. 2006 Oct;21(10):1525-32.

PMID:
16928212
13.

Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.

Moskovitz DN, Osiowy C, Giles E, Tomlinson G, Heathcote EJ.

J Viral Hepat. 2005 Jul;12(4):398-404.

PMID:
15985011
14.
15.

Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.

Huang YH, Wu JC, Chang TT, Sheen IJ, Huo TI, Lee PC, Su CW, Lee SD.

J Viral Hepat. 2006 May;13(5):336-42. Erratum in: J Viral Hepat. 2008 Feb;15(2):156.

PMID:
16637865
16.

Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.

Shin JW, Chung YH, Choi MH, Kim JA, Ryu SH, Jang MK, Kim IS, Park NH, Lee HC, Lee YS, Suh DJ.

J Gastroenterol Hepatol. 2005 Jun;20(6):844-9.

PMID:
15946130
17.

Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong.

Yuen MF, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, Yuan HJ, Wong DK, Sum SM, Lai CL.

J Hepatol. 2004 Jul;41(1):119-25.

PMID:
15246217
18.

Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels.

Bozdayi AM, Bozkaya H, Türkyilmaz AR, Sarýodlu M, Cetinkaya H, Karayalçin S, Yurdaydin C, Uzunalimoğlu O.

J Clin Virol. 2001 Apr;21(1):91-101.

PMID:
11255102
19.
20.

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B.

Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS.

J Gastroenterol. 2002;37(4):283-7.

PMID:
11993512

Supplemental Content

Support Center